S Basaria

Summary

Affiliation: Boston University School of Medicine
Country: USA

Publications

  1. pmc Welcoming low testosterone as a cardiovascular risk factor
    M Maggio
    Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Parma, Parma, Italy
    Int J Impot Res 21:261-4. 2009
  2. pmc Safety and efficacy of testosterone gel in the treatment of male hypogonadism
    Kishore M Lakshman
    Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, Boston Medical Center, Boston, MA 02118, USA
    Clin Interv Aging 4:397-412. 2009
  3. pmc Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial
    Grace Huang
    Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, 670 Albany Street, Boston, MA02118, USA
    J Gerontol A Biol Sci Med Sci 68:954-9. 2013
  4. pmc Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation
    Shehzad Basaria
    Department of Internal Medicine, Boston University School of Medicine, 670 Albany Street, Suite 205, Boston, MA 02118, USA
    J Gerontol A Biol Sci Med Sci 68:153-60. 2013
  5. ncbi request reprint Androgen abuse in athletes: detection and consequences
    Shehzad Basaria
    Department of Medicine, Division of Endocrinology and Metabolism, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Clin Endocrinol Metab 95:1533-43. 2010
  6. ncbi request reprint Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women
    S Basaria
    Department of Internal Medicine, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Endocrinol Invest 32:150-5. 2009
  7. doi request reprint Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men
    C Cattabiani
    Department of Internal Medicine and Biomedical Sciences, Section of Geriatrics, University of Parma, Parma, Italy
    J Endocrinol Invest 35:104-20. 2012
  8. ncbi request reprint Preventing skeletal complications in androgen deprived men with prostate cancer: Time for action
    M Braga-Basaria
    Division of Endocrinology, Department of Medicine, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    J Endocrinol Invest 29:467-70. 2006
  9. ncbi request reprint Androgens and erythropoiesis: past and present
    S Shahani
    Division of Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, USA
    J Endocrinol Invest 32:704-16. 2009
  10. ncbi request reprint Hypogonadism and androgen replacement therapy in elderly men
    S Basaria
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Med 110:563-72. 2001

Collaborators

Detail Information

Publications18

  1. pmc Welcoming low testosterone as a cardiovascular risk factor
    M Maggio
    Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Parma, Parma, Italy
    Int J Impot Res 21:261-4. 2009
    ..Recent studies have shown low serum testosterone levels to be an independent risk factor of cardiovascular and all-cause mortality. It is time to welcome low serum testosterone levels as a cardiovascular risk factor...
  2. pmc Safety and efficacy of testosterone gel in the treatment of male hypogonadism
    Kishore M Lakshman
    Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, Boston Medical Center, Boston, MA 02118, USA
    Clin Interv Aging 4:397-412. 2009
    ..Androgel and Testim, the two currently available testosterone gel products in the US, have certain brand-specific properties that clinicians may consider prior to prescribing...
  3. pmc Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial
    Grace Huang
    Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, 670 Albany Street, Boston, MA02118, USA
    J Gerontol A Biol Sci Med Sci 68:954-9. 2013
    ....
  4. pmc Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation
    Shehzad Basaria
    Department of Internal Medicine, Boston University School of Medicine, 670 Albany Street, Suite 205, Boston, MA 02118, USA
    J Gerontol A Biol Sci Med Sci 68:153-60. 2013
    ..We evaluated changes in gonadal hormones and markers of inflammation and coagulation to elucidate risk factors associated with cardiovascular events...
  5. ncbi request reprint Androgen abuse in athletes: detection and consequences
    Shehzad Basaria
    Department of Medicine, Division of Endocrinology and Metabolism, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Clin Endocrinol Metab 95:1533-43. 2010
    ..With increasing availability of designer androgens, significant efforts are needed by antidoping authorities to develop sensitive methods to detect their use...
  6. ncbi request reprint Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women
    S Basaria
    Department of Internal Medicine, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Endocrinol Invest 32:150-5. 2009
    ..Isoflavones, a class of plant estrogens, have structural similarities to estradiol. Hence, isoflavones may exert beneficial estrogenic health effects in postmenopausal women with fewer adverse effects...
  7. doi request reprint Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men
    C Cattabiani
    Department of Internal Medicine and Biomedical Sciences, Section of Geriatrics, University of Parma, Parma, Italy
    J Endocrinol Invest 35:104-20. 2012
    ..Finally we will detail the emerging relationship between low T and mortality in men addressing also the reverse hypothesis that low T has a protective role by turning off T-dependent functions...
  8. ncbi request reprint Preventing skeletal complications in androgen deprived men with prostate cancer: Time for action
    M Braga-Basaria
    Division of Endocrinology, Department of Medicine, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    J Endocrinol Invest 29:467-70. 2006
  9. ncbi request reprint Androgens and erythropoiesis: past and present
    S Shahani
    Division of Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, USA
    J Endocrinol Invest 32:704-16. 2009
    ....
  10. ncbi request reprint Hypogonadism and androgen replacement therapy in elderly men
    S Basaria
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Med 110:563-72. 2001
    ..This review summarizes the trials of testosterone replacement therapy in elderly men and outlines a diagnostic approach to these patients...
  11. ncbi request reprint Andropause: to treat or not to treat?
    S Basaria
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore 21224, USA
    J Endocrinol Invest 26:693-7. 2003
  12. pmc Sex hormone binding globulin levels across the adult lifespan in women--the role of body mass index and fasting insulin
    M Maggio
    Department of Internal Medicine and Biomedical Sciences, Section of Geriatrics, School of Endocrinology, University of Parma, Parma, Italy
    J Endocrinol Invest 31:597-601. 2008
    ..00039 to 0.00028). SHBG levels show an age-related U-shaped trajectory. These changes mirror the age-related changes in BMI and fasting insulin, suggesting that BMI and insulin negatively influence SHBG concentration...
  13. ncbi request reprint Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy
    M Braga-Basaria
    Department of Medicine, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    Int J Impot Res 18:494-8. 2006
    ..Long-term prospective studies are needed to determine the time of onset of changes in these lipoproteins while on ADT and the influence of these changes on cardiovascular mortality...
  14. ncbi request reprint Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases
    S Basaria
    The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 86:5108-17. 2001
    ....
  15. pmc The effect of testosterone on mood and well-being in men with erectile dysfunction in a randomized, placebo-controlled trial
    M Spitzer
    Section of Endocrinology Diabetes and Nutrition, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA
    Andrology 1:475-82. 2013
    ..Our findings show that the addition of testosterone to sildenafil in men with ED and low serum testosterone levels was not associated with improvement in either well-being or mood...
  16. doi request reprint Androgen deprivation therapy for prostate cancer: implications for cardiometabolic clinical care
    L Collins
    Boston University Medical Center, Boston, MA, USA
    J Endocrinol Invest 35:332-9. 2012
    ..This paper serves as a focused review of recent studies examining the metabolic abnormalities and cardiovascular disease related to ADT...
  17. ncbi request reprint Andropause: need for concrete guidelines until more evidence becomes available
    S Basaria
    Division of Endocrinology, Department of Medicine, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    J Endocrinol Invest 28:667-70. 2005
  18. pmc High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer
    Joshua K Napora
    National Institute of Health, National Institute on Aging, Laboratory of Clinical Investigation, Diabetes Section, Baltimore, Maryland, USA
    J Androl 32:40-8. 2011
    ..We found that high-dose isoflavones over a course of 12 weeks do not improve metabolic or inflammatory parameters in androgen-deprived men...